Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

ClinicalTrials.gov ID: NCT00650468

Public ClinicalTrials.gov record NCT00650468. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long Term Corticosteroid Therapy With Prograf and CellCept in Primary Renal Transplant Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study comparing the early withdrawal of steroids to long-term maintenance steroid therapy in Kidney Transplant Patients receiving Prograf and Cellcept

Study identification

NCT ID
NCT00650468
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
397 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1999 (Type not available)
Primary completion
Dec 2007 (Actual)
Completion
Dec 2007 (Actual)
Last update posted
Nov 17, 2011

1999 – 2007

United States locations

U.S. sites
29
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72205 —
Not listed Loma Linda California 92354 —
Not listed Los Angeles California 90057 —
Not listed Denver Colorado 80262 —
Not listed Chicago Illinois 60637 —
Not listed Lexington Kentucky 40536 —
Not listed New Orleans Louisiana 70121 —
Not listed Baltimore Maryland 21201 —
Not listed Boston Massachusetts 02111 —
Not listed Detroit Michigan 48202 —
Not listed Minneapolis Minnesota 55455 —
Not listed Rochester Minnesota 55905 —
Not listed Omaha Nebraska 68198 —
Not listed New Brunswick New Jersey 08903 —
Not listed Buffalo New York 14203 —
Not listed New York New York 10021 —
Not listed New York New York 10029 —
Not listed Cincinnati Ohio 45267 —
Not listed Cleveland Ohio 44106 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Providence Rhode Island 02903 —
Not listed Memphis Tennessee 38163 —
Not listed Nashville Tennessee 37232 —
Not listed Galveston Texas 77555 —
Not listed San Antonio Texas 78229 —
Not listed Salt Lake City Utah 84103 —
Not listed Salt Lake City Utah 84132 —
Not listed Madison Wisconsin 53792 —
Not listed Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00650468, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2011 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00650468 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →